A Biotech Short-Seller Responds to Critics – CNBC

July 17, 2012 Posted By: Leave a comment
The war against biotech short sellers is heating up once again. Short selling is never going to be a wildly popular investing practice, but it is perfectly legal and essential for the proper function of the capital markets. But recently, a public watchdog ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>